Support teaching, research, and patient care.
Leukocyte recruitment & immune responses in diseases affecting digestive organs
Ulcerative Colitis - Vedolizumab- With/Without Prior Exposure to Anti-TNF（Tumor Necrosis Factor）Therapy Not Recruiting
A case-control study to evaluate the immunoinflammatory effect of prior exposure to anti-TNF therapy in patients with ulcerative colitis starting vedolizumab therapy
Stanford is currently not accepting patients for this trial. For more information, please contact John Gubatan, MD, 650-736-5555.
View full details
Gastric Acid Suppression and Probiotic Colonization Not Recruiting
Probiotics are over-the-counter dietary products with microorganisms that are generally consumed for health benefit. However, the durability of these microorganisms is unclear, particularly when they pass through the highly acidic environment of the stomach. We will test the colonization of these microorganisms among individuals who consume probiotics with and without acid suppression therapy.
Stanford is currently not accepting patients for this trial. For more information, please contact Berkeley Limketkai, 650-736-0431.
Localized Therapeutics for the Treatment of Gastrointestinal Disorders Not Recruiting
The purpose of this study is to determine the patient preference for a biocompatible thermosensitive solution-gel versus water or saline (liquid) enema. The thermosensitive solution-gel is comprised of poloxamer, an inactive compound that is designated as GRAS (generally recognized as safe) by FDA. It could subsequently be used as a medium for drug delivery. The poloxamer (gel) is administered to study participants in order to assess preference and proximal distribution.
Stanford is currently not accepting patients for this trial. For more information, please contact Sidhartha Sinha, MD, .
